论文部分内容阅读
为了探索将不同孕期胎盘激素及有关生物活性物质含量变化做为产前监护指标应用的价值,作者对381例孕妇分别用放射免疫分析测定了 HPL、HCG、HCG-β、HBsAg、AFP,皮质醇、铁蛋白等项目并结合产前保健检查和必要的 B 型超声、染色体检测等内容做了对照分析,结果显示:①50例 HBsAg 阳性孕妇中胎儿出生体重小于或等于2500克者6例,占12%;早产4例,占8%,流产者3例,占6%。26例 HBsAg 阴性孕妇中,低体重儿
In order to explore the different levels of placental hormone and related bioactive substances in pregnancy as the value of the application of prenatal care indicators, the authors of 381 pregnant women were measured by radioimmunoassay HPL, HCG, HCG-β, HBsAg, AFP, cortisol , Ferritin and other items in combination with prenatal health checks and the necessary B-mode ultrasound, chromosome detection and other content were analyzed, the results showed that: ①50 cases of HBsAg-positive pregnant women birth weight less than or equal to 2500 grams in 6 cases, accounting for 12 %; 4 cases of premature birth, accounting for 8%, 3 cases of abortion, accounting for 6%. 26 cases of HBsAg-negative pregnant women, low birth weight children